Indian Startup Secures Interim Injunction in PIP Patent Dispute with Canva
The Delhi High Court granted an interim injunction to Rxprism Health Systems against Canva over a PIP patent dispute. The Court found a prima facie case of infringement…
201 articles
The Delhi High Court granted an interim injunction to Rxprism Health Systems against Canva over a PIP patent dispute. The Court found a prima facie case of infringement…
This article analyses regulatory data protection in India under TRIPS and domestic law. It discusses the balance between originator protection and access to generic medicines, highlighting the implications…
Dr Kalyan C Kankanala has opposed Stephen Thaler's Indian patent application that names AI as the inventor. The post analyses the legal position of AI inventorship under Indian…
This article explores when and how abandoned or lapsed patents and patent applications may be revived in India, referencing key court decisions. It provides practical legal insights on…
This post reviews the legal principles for filing divisional patent applications in India, focusing on the requirement for a plurality of inventions in the parent application's claims. It…
This case brief discusses the Delhi High Court's decision in European Commission vs Union of India regarding the restoration of patent applications deemed abandoned due to procedural lapses.…
The Delhi High Court ruled on a patent infringement dispute involving a self-propelled dolly for vehicle transfer in car parks. The Court found infringement despite technical differences and…
This post analyses major Indian patent case laws from 2021, with a focus on Delhi High Court decisions involving interim injunctions and pharmaceutical patents. It offers an objective…
This article examines recent patent litigation before the Delhi High Court, highlighting cases involving Novartis and Sulphur Mills in 2021. It discusses key judicial findings on patent validity,…
This article summarises pivotal Delhi High Court decisions on patent disputes in 2021, particularly involving pharmaceutical products. The analysis covers interim injunctions and key arguments in Indian patent…